Research Article Details

Article ID: A13559
PMID: 29912573
Source: Arch Physiol Biochem
Title: Association of tissue inhibitor of metalloproteinase 2 with non-alcoholic fatty liver disease in metabolic syndrome.
Abstract: The aim of this case-control study was to assess TIMP2 level in subjects with or without metabolic syndrome (MetS) and to associate levels with non-alcoholic fatty liver changes (NAFLD). Thirty-three MetS subjects and 55 controls were recruited. Anthropometric data, lipid and glucose profile, TIMP2 and liver ultrasound was performed. High TIMP2 was seen in MetS group (145.28&#8201;&#177;&#8201;23.11&#8201;pg/ml) versus controls (19.06&#8201;&#177;&#8201;1.19&#8201;pg/ml; p&#8201;<&#8201;.001). Serum cholesterol, triglyceride, LDL-c and glucose levels were significantly higher in MetS subjects (p&#8201;<&#8201;.05). MetS individuals (72.72%) showed positive fatty liver changes versus 14.5% controls. Elevated TIMP2 positively correlated with waist circumference, body fat, blood glucose and NAFLD. Furthermore, every unit rise in waist circumference and TIMP2 and a unit decrease in HDL were associated with higher odds of developing NAFLD (p&#8201;<&#8201;.05). There may be concurrent relationship between TIMP2 and NAFLD in MetS that requires further evaluation to improve risk assessment and early diagnosis of MetS.
DOI: 10.1080/13813455.2018.1481095